Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma
NCT04056962
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma
Interventions
DRUG:
Tacrolimus ointment
Sponsor
West China Hospital